Rizwana Mohseni
- Epidemiology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Molecular Biology
- Hepatology top 10%
- Cell Biology
- Co-authors
- Michelle LaiKris V. KowdleyKenneth CusiPankaj PatelSamer GawriehNaga ChalasaniDhruvanshu ParmarNicole Loo
- Topics
- Liver Disease Diagnosis and Treatment (6 papers)Diet, Metabolism, and Disease (3 papers)Cancer, Lipids, and Metabolism (2 papers)
- Journals
- SHILAP Revista de lepidopterologíaGastroenterologyHepatology
- Partner nations
- United StatesHong KongIndia
In The Last Decade
Rizwana Mohseni
5 papers receiving 475 citations
Hit Papers
Peers
Comparison fields: 5 of 44
- Epidemiology 404
- Endocrinology, Diabetes and Metabolism 217
- Molecular Biology 133
- Hepatology 116
- Cell Biology 93
Countries citing papers authored by Rizwana Mohseni
This map shows the geographic impact of Rizwana Mohseni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizwana Mohseni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizwana Mohseni more than expected).
Fields of papers citing papers by Rizwana Mohseni
This network shows the impact of papers produced by Rizwana Mohseni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizwana Mohseni. The network helps show where Rizwana Mohseni may publish in the future.
Co-authorship network of co-authors of Rizwana Mohseni
This figure shows the co-authorship network connecting the top 25 collaborators of Rizwana Mohseni. A scholar is included among the top collaborators of Rizwana Mohseni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizwana Mohseni. Rizwana Mohseni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trialbreakdown → | 261 |
| 3 | TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trialbreakdown → | 163 |
| 4 | 3 | |
| 5 | 7 | |
| 6 | 50 |
About Rizwana Mohseni
Rizwana Mohseni is a scholar working on Hepatology, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 6 papers that have together received 484 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Diet, Metabolism, and Disease (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Hepatology (116 citations), Endocrinology, Diabetes and Metabolism (217 citations) and Epidemiology (404 citations). Rizwana Mohseni has collaborated with scholars based in United States, Hong Kong and India. Frequent co-authors include Michelle Lai, Kris V. Kowdley, Kenneth Cusi, Pankaj Patel, Samer Gawrieh, Naga Chalasani, Dhruvanshu Parmar, Nicole Loo, Eugene R. Schiff and Mazen Noureddin. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.